Cohort 8.0 founders Garland Surgical have been awarded up to €1.4 million in grant funding by Malta Enterprise.
We are incredibly excited to bring you some fantastic news from Cohort 8.0 founders Garland Surgical. Garland, who are developing a revolutionary longer-lasting hip replacement - the MaltaHip have been approved for up to €1.4 million in grant funding by Malta Enterprise - the economic development agency for Malta.
Aimed at helping Garland push the MaltaHip towards regulatory approval and market launch, Malta Enterprise's grant offering also includes laboratory space at the Malta Life Sciences Park, key for further research and development.
We are tremendously proud to see the confidence and support that has been generated in the MaltaHip project and look forward to seeing the continued journey towards fully-fledged public use.
To read the full LinkedIn post from Garland Surgical, use the link here.
04 Apr 2025 | Cohort Successes
BetaDen Accelerate Cohort 2.0 alumni Utelize picked up a win in the 'Enterprise IoT eSim Product'...
28 Mar 2025 | Cohort Successes
We are proud to share that BetaDen's Cohort 8.0 Alumni Smart90 have been shortlisted for the...
10 Mar 2025 | Cohort Successes
A leading logistics software firm is heading in a new direction following a share buyback by one of...
